Directory

>

Mike Sherman

Mike Sherman

Member Board of Directors | Chimerix, Inc.

Carmel, Indiana, United States

View contact details (it's free)

Mike Sherman

Summary

Mike Sherman is a seasoned life science executive with extensive experience in biotechnology and pharmaceutical industries. Currently serving as a Board Director at Werewolf Therapeutics and Chairman of the Board at Chimerix, he has a proven track record of successfully repositioning companies and leading them to significant milestones, including FDA approvals and strategic acquisitions. His leadership at Chimerix resulted in the sale of TEMBEXA, enhancing public health safety. Mike's strategic vision in oncology drug development is exemplified by the promising ONC201 trial, which targets brain cancer in children and young adults. He previously played pivotal roles at Endocyte, where he guided the company towards radioligand therapy and led its acquisition by Novartis. With a BA in Economics from DePauw University and an MBA from Dartmouth's Tuck School, Mike combines strong academic credentials with practical expertise in finance and strategic planning. His commitment extends beyond corporate roles to community service as a past Chairman of the Board for the Children's Museum of Indianapolis.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Industry-specific interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Startup Experience

Corporate Experience

Consulting Experience

Mike Sherman

Work Experience

company logo

Member Board of Directors at

TOLREMO therapeutics

March 2024 - Present

company logo

Board Chair at

Chimerix, Inc.

August 2023 - Present

company logo

Member Board Of Directors at

Werewolf Therapeutics

May 2021 - Present

company logo

President and CEO, Chimerix at

Chimerix, Inc.

April 2019 - August 2023

company logo

Board Of Trustees and Past Chair at

The Children's Museum of Indianapolis

January 2012 - December 2022

💼

Member Board Of Directors at

Biospecifics Technologies

April 2020 - December 2020

company logo

President and CEO at

Endocyte

June 2016 - January 2019

company logo

Member Board Of Directors at

Mead Johnson Nutrition

February 2015 - June 2017

company logo

Chief Operating Officer & Chief Financial Officer at

Endocyte

June 2014 - June 2016

company logo

CFO at

Endocyte

January 2007 - June 2014

company logo

VP Finance and Strategic Planning at

Boston Scientific

January 2005 - January 2006

company logo

VP Finance & IT Europe at

Boston Scientific

January 2002 - January 2005

company logo

Controller, Chief Accounting Officer at

Boston Scientific

January 2000 - January 2002

company logo

Various financial and business development roles at

Boston Scientific

January 1992 - January 2000

company logo

Various financial and business development roles at

Eli Lilly and Company

January 1988 - January 1992

Logos provided by Logo.dev

Mike Sherman

Education

Dartmouth College - The Tuck School of Business at Dartmouth, Master Of Business Administration (M.B.A.)

January 1990 - January 1992

DePauw University, Ba

January 1984 - January 1988

Broad Ripple

Broad Ripple

Frequently Asked Questions about Mike Sherman

What is Mike Sherman email address?

Mike Sherman's primary email address is ********@chimerix.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Mike Sherman work for?

Mike Sherman is a Member Board of Directors at Chimerix, Inc., a company specializing in Commercial physical research.

Where Mike Sherman graduated from?

Mike Sherman holds a degree in from Dartmouth College - The Tuck School of Business at Dartmouth.

How can I directly contact Mike Sherman?

To contact Mike Sherman directly, you can use the email address ********@chimerix.com. Complete contact information is available upon registration with Muraena.

Who is Mike Sherman?

Mike Sherman is a seasoned life science executive with extensive experience in biotechnology and pharmaceutical industries. Currently serving as a Board Director at Werewolf Therapeutics and Chairman of the Board at Chimerix, he has a proven track record of successfully repositioning companies and leading them to significant milestones, including FDA approvals and strategic acquisitions. His leadership at Chimerix resulted in the sale of TEMBEXA, enhancing public health safety. Mike's strategic vision in oncology drug development is exemplified by the promising ONC201 trial, which targets brain cancer in children and young adults. He previously played pivotal roles at Endocyte, where he guided the company towards radioligand therapy and led its acquisition by Novartis. With a BA in Economics from DePauw University and an MBA from Dartmouth's Tuck School, Mike combines strong academic credentials with practical expertise in finance and strategic planning. His commitment extends beyond corporate roles to community service as a past Chairman of the Board for the Children's Museum of Indianapolis.

Mike`s contact details

mail

********@chimerix.com

********@endocyte.com

************@bsci.com

********@werewolftx.com

Colleagues

avatar
Norlonn Sturdivant Mt Rac

Executive Director of Quality Assurance

avatar
Tom Brundage

Vice President, Biostatistics

avatar
Joshua Allen

Chief Scientific Officer

Barbara Berg

Executive Director, Human Resources

Christopher Jordan

Vice President Regulatory Affairs

avatar
Heidi Colton

Executive Director, Nonclinical Development Strategy and Translational Medicine

Odin Naderer

VP Clinical Pharmacology/Translational Medicine

View Contact details (it's free)
Request Profile Removal